TCL Archive $14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists October 24, 1996
TCL Archive Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve. April 13, 2007
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
